Utama › Penyakit Sel Sabit › Texas › Houston
Kajian klinikal Penyakit Sel Sabit di Houston, TX
10 kajian untuk Penyakit Sel Sabit sedang mencari peserta di lokasi dalam dan sekitar Houston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Mengambil pesertaFasa 3
- Texas Childrens Cancer and Hematology Center, Houston
- U of TX Health Science Ct, Houston
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Mengambil pesertaFasa 3
- Texas Children's Hospital_Houston, Houston
- UT Health University of Texas, Houston
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Mengambil pesertaFasa 3
- UT Health University of Texas, Houston
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
- UT Health Science Center, Houston
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Mengambil pesertaKajian pemerhatian
- Gulf States Hemophilia and Thrombophilia Center, Houston
- Texas Children's Hemophilia & Thrombosis Center/Baylor College of Medicine, Houston
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Mengambil pesertaFasa 3
- Baylor College of Medicine- Site Number : 8400055, Houston
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
Mengambil pesertaKajian pemerhatian
- Texas Children's Hopsital (NT-DMT), Houston
- Texas Children's Hospital (MRD-HCT), Houston
Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
Mengambil pesertaFasa 3
- Site # 8400004, Houston
Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
Mengambil pesertaFasa 2
- Baylor College of Medicine, Houston
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
Mengambil pesertaKajian pemerhatian
- University of Texas at Houston, Houston
Kajian Penyakit Sel Sabit di bandar lain
- Atlanta, GA22 kajian
- Washington, DC20 kajian
- Memphis, TN18 kajian
- Chicago, IL18 kajian
- Philadelphia, PA15 kajian
- Birmingham, AL14 kajian
- New York City, NY13 kajian
- St. Louis, MO12 kajian
- Durham, NC10 kajian
- Cincinnati, OH10 kajian
- Boston, MA10 kajian
- Pittsburgh, PA9 kajian
Kajian lain di Houston
- Kanser Paru-paru Bukan Sel Kecil145 kajian
- Kanser Payudara126 kajian
- Kanser (semua jenis)121 kajian
- Kanser Metastatik104 kajian
- Kanser Kolorektal102 kajian
- Kanser Ovari89 kajian
- Leukemia Mieloid Akut85 kajian
- Kanser Paru-paru78 kajian
- Kanser Prostat76 kajian
- Kanser Endometrium68 kajian
- Kanser Pankreas61 kajian
- Melanoma59 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.